DOXORUBICIN vs ETOPOSIDE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DOXORUBICIN vs ETOPOSIDE: Safety Overview
| Metric | DOXORUBICIN | ETOPOSIDE |
|---|---|---|
| Total FAERS Reports | 82,754 | 52,603 |
| Deaths Reported | 15,653 | 11,780 |
| Death Rate | 18.9% | 22.4% |
| Hospitalizations | 28,630 | 17,699 |
| Average Patient Age | 50.5 yrs | 42.5 yrs |
| % Female Patients | 53.9% | 41.8% |
| FDA Approval Date | Approved Prior to Jan 1, 1982 | Aug 30, 1995 |
| Manufacturer | Hikma Pharmaceuticals USA Inc. | Avyxa Pharma, LLC |
| Route | INTRAVENOUS | INTRAVENOUS |
| Marketing Status | Discontinued | Discontinued |